Developing a new drug for spinal cord injury treatment
NEURESTA DRUG SUBSTANCE MANUFACTURING
This study is working on a new drug called NgR(310)Fc [AXER-204] that aims to help people with spinal cord injuries, and it's all about making enough of the drug to test it safely in humans to see if it can really make a difference.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Leidos Biomedical Research, INC. NIH-funded |
| Lab location | 1 site (Frederick, United States) |
| Project ID | NIH-11219236 on NIH RePORTER |
What this research studies
This research focuses on the development of a drug called NgR(310)Fc [AXER-204] aimed at treating spinal cord injuries. The project involves producing this drug in sufficient quantities for use in human clinical trials, ensuring high-quality manufacturing and compliance with regulatory standards. The research team will manage various aspects including technical project management, quality evaluation, and logistics to support the drug's development. Patients with spinal cord injuries may benefit from this innovative treatment if it proves effective in clinical settings.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have experienced spinal cord injuries or related conditions.
Not a fit: Patients with conditions unrelated to spinal cord injuries may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a new treatment option for individuals suffering from spinal cord injuries.
How similar studies have performed: Previous research has shown promise in developing biologics for spinal cord injuries, indicating potential for success in this area.
Where this research is happening
Frederick, United States
- Leidos Biomedical Research, INC. — Frederick, United States (Active)
Researchers
- Principal investigator: Briscoe, Lynn — Leidos Biomedical Research, INC.
- Study coordinator: Briscoe, Lynn
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.